The last day of operation for Hertfordshire and West Essex ICB was 31 March 2026. The information on this website has not been updated since 31 March 2026. The legacy policies, prescribing recommendations and pathways can be accessed on this website. Find out more

Indication
Preventing HIV-1
RAG rating
Red
Document type
NICE technology appraisal
Place
Hertfordshire and West Essex ICB
Output type
Pharmacy / Prescribing

Cabotegravir

Cabotegravir (Apretude®)

HERTFORDSHIRE AND WEST ESSEX AREA PRESCRIBING COMMITTEE (HWE APC)
Cabotegravir for preventing HIV-1 in adults and young people

RED
This technology is the commissioning responsibility of local authorities for restricted prescribing by Sexual health service providers only.
Not recommended for primary care prescribing.

Name generic (trade): Cabotegravir (Apretude®) injection
What it is: Antiviral – Integrase inhibitor 
Indication: preventing HIV-1 in adults and young people.
Date: December 2025
NICE: NICE TA1106 

In line with NICE TA1106  - This technology is the commissioning responsibility of local authorities for restricted prescribing by Sexual health service providers only. Not recommended for primary care prescribing.

Back